Literature DB >> 15817572

Influence of caspase activity on micronuclei detection: a possible role for caspase-3 in micronucleation.

Ilse Decordier1, Enrico Cundari, Micheline Kirsch-Volders.   

Abstract

Aneugenic and clastogenic agents are good inducers of both micronuclei and apoptosis. In its turn, apoptosis may modify the threshold values for the induction of micronuclei. This is of major concern for accurate assessment of hazard related to exposure to mutagens. In the present work we studied the influence of caspases, the key regulators of the apoptotic process, on the induction of micronuclei in the cytokinesis block micronucleus assay. For this, we applied a combined approach in which both human peripheral blood mononucleated cells (PBMC) and the paired human breast carcinoma cell lines MCF-7, which is caspase-3 deficient, and the caspase-3 transfected MCF-7 (MCF-7casp-3) were used to study the influence of caspase activity on micronuclei. When nocodazole induced apoptosis was inhibited by the use of inhibitors of the two main apical caspases-8 and -9 in PBMC, the frequencies of micronucleated binucleates (MNCB) increased with inhibition of these caspases confirming that apoptosis can eliminate micronucleated cells. On the contrary when caspase-3 was inhibited, the frequencies of MNCB was lower, suggesting a role of caspase-3, also in micronuclei formation. To verify this hypothesis, we compared the induction of apoptosis and micronuclei by the aneugen nocodazole, the clastogen methyl methane sulfonate (MMS) and the non-mutagenic apoptogen staurosporin in MCF-7 and MCF-7casp-3 cells. The results showed that when caspase-3 activity was impaired, in the parental MCF-7 cell line or in the MCF-7casp-3 cells in the presence of the caspase-3 inhibitor, the frequencies of nocodazole or MMS induced micronuclei decreased. These results suggest that caspase-3, besides its function as an effector caspase in the apoptotic pathway, is also involved in the formation of micronuclei.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15817572     DOI: 10.1093/mutage/gei025

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  6 in total

1.  Ferrocenes as potential chemotherapeutic drugs: synthesis, cytotoxic activity, reactive oxygen species production and micronucleus assay.

Authors:  Wanda I Pérez; Yarelys Soto; Carmen Ortíz; Jaime Matta; Enrique Meléndez
Journal:  Bioorg Med Chem       Date:  2014-12-19       Impact factor: 3.641

2.  Long-term fate of etoposide-induced micronuclei and micronucleated cells in Hela-H2B-GFP cells.

Authors:  Hauke Reimann; Helga Stopper; Henning Hintzsche
Journal:  Arch Toxicol       Date:  2020-07-17       Impact factor: 5.153

3.  Retracted Article: The synthesis and biological activity of marine alkaloid derivatives and analogues.

Authors:  Shiyang Zhou; Gangliang Huang
Journal:  RSC Adv       Date:  2020-08-28       Impact factor: 4.036

4.  Micronuclei in genotoxicity assessment: from genetics to epigenetics and beyond.

Authors:  Lidiya Luzhna; Palak Kathiria; Olga Kovalchuk
Journal:  Front Genet       Date:  2013-07-11       Impact factor: 4.599

5.  Inducible Protective Processes in Animal Systems XIII: Comparative Analysis of Induction of Adaptive Response by EMS and MMS in Ehrlich Ascites Carcinoma Cells.

Authors:  Periyapatna Vishwaprakash Mahadimane; Venkateshaiah Vasudev
Journal:  Scientifica (Cairo)       Date:  2014-06-04

6.  Synthesis and biological evaluation of novel 3-alkylpyridine marine alkaloid analogs with promising anticancer activity.

Authors:  Alessandra Mirtes Marques Neves Gonçalves; Aline Brito de Lima; Maria Cristina da Silva Barbosa; Luiz Fernando de Camargos; Júlia Teixeira de Oliveira; Camila de Souza Barbosa; José Augusto Ferreira Perez Villar; André Carvalho Costa; Isabella Viana Gomes da Silva; Luciana Maria Silva; Fernando de Pilla Varotti; Fabio Vieira dos Santos; Gustavo Henrique Ribeiro Viana
Journal:  Mar Drugs       Date:  2014-07-31       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.